Likewise, Borghi et al. conducted a prospective study in 62 patients with PLP who received 0.5% ropivacaine intra-operatively 5 ml/h continued for an average of 30 post-operative days.
Así mismo, Borghi et al. realizaron un estudio prospectivo en 62 pacientes con DMF a quienes se les administró ropivacaína 0,5% intraoperatoriamente 5 ml/h continuando en promedio durante 30 días posoperatorio.